Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07459569
Eligibility Criteria:
Inclusion Criteria:
* Age 18 years or older;
* Presence of unexplained mediastinal lymphadenopathy (short-axis diameter ≥1 cm on chest computed tomography) with clinical suspicion of tuberculosis;
* Completion of routine pre-procedural evaluations including blood tests (complete blood count, coagulation profile), electrocardiogram, and chest CT;
* Absence of contraindications for EBUS-TBNA or EBUS-TBMC procedures;
* Provision of written informed consent after being fully informed of the study purpose and procedures.
Exclusion Criteria:
* Known allergy to lidocaine or midazolam;
* Presence of bronchial artery penetration into the target lesion or high risk of bleeding as detected by contrast-enhanced CT or EBUS Doppler mode prior to the procedure;
* Unstable angina, congestive heart failure, or severe bronchial asthma;
* Evidence of significant liquefaction necrosis in the target mediastinal lymph node on pre-procedural CT or EBUS;
* Patient refusal to participate in the study;
* Participation in another clinical trial within the past three months that may interfere with the outcomes of this study;
* Any other condition that, in the opinion of the investigator, makes the patient unsuitable for study participation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07459569
Study Brief:
Protocol Section:
NCT07459569